CDXS Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: March 12, 2026
Report Source: 2025 Annual Report
Codexis Inc. Stock Analysis CDXS
Codexis, Inc. is an enzyme engineering company, which engages in the development and sale of therapeutics. The company is headquartered in Redwood City, California and currently employs 146 full-time employees. The company went IPO on 2010-04-22. The company is leveraging its CodeEvolver technology platform to discover, develop, enhance, and commercialize novel, high-performance enzymes and other classes of proteins. The firm utilizes its CodeEvolver technology platform to develop optimized enzymes that are used by some pharmaceutical companies to reduce their costs and improve the efficiency and productivity of their manufacturing processes for small molecule therapeutics. The company is developing its Enzyme-Catalyzed Oligonucleotide Synthesis (ECO Synthesis) manufacturing platform to enable the scaled manufacture of RNA interference (RNAi) and other RNA-based therapeutics through an enzymatic route. The firm also uses the CodeEvolver platform technology to develop enzymes for the synthesis of RNAi therapeutics through its ECO Synthesis manufacturing platform, where its enzymes are poised to deliver many of the same benefits it offers in pharmaceutical manufacturing.
Read More Codexis Inc (CDXS) Chart
Key Statistics of Codexis Inc (CDXS)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$2.50Volume
773.94KP/E Ratio (TTM)
-52 Week Range
Market Cap
249.89MAvg. Volume
1.27MDividend Yield
-Financial Metrics & Statements of Codexis Inc (CDXS)
FAQ's for Codexis Inc (CDXS)
- According to Musaffa’s Shariah screening methodology, Codexis Inc (CDXS) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.